EGFR and lung cancer: TNF inhibition via TNFRSF1A silencing, etanercept, or thalidomide increases sensitivity of lung cancer cells to EGFR-TKIs, whereas TNF overexpression attenuates apoptosis induction by EGFR-TKIs (54).